Publication | Closed Access

Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy

Cell-based Drug DeliveryNanomedicineEngineeringPolymer-drug ConjugateMedicineNano-drug DeliveryPharmacotherapyBiomedical EngineeringSynergistic TherapyDrug Delivery SystemPharmacology